Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Single Dose PG102 in Patients With Active Psoriatic Arthritis
- First Posted Date
- 2008-11-07
- Last Posted Date
- 2010-10-26
- Lead Sponsor
- PanGenetics UK Limited
- Target Recruit Count
- 17
- Registration Number
- NCT00787137
- Locations
- 🇷🇸
Professor Nemanja Damjanov, Belgrade, Serbia
News
No news found